Lancashire and South Cumbria
Formulary
 
back
3 Respiratory system

When prescribing inhalers the drug, device (e.g. MDI, Easibreathe, Autohaler, Accuhaler), strength (micrograms per inhalation), number of puffs per dose and frequency MUST be specified

03-01-01-01 Long-acting beta2 agonists

 In patients with asthma long-acting beta2  agonists SHOULD only be prescribed when they are already receiving inhaled corticosteroids, it is therefore recommended that a combination ICS/LABA is considered for patients with asthma to avoid inadvertent monotherapy with a LABA. In patients with COPD long-acting beta2  agonists it is now recommended that they SHOULD only be prescribed with either an inhaled corticosteroid (if asthmatic features present) or a long acting muscarinic antagonist (if no asthmatic features) REF NICE NG 115, GOLD 2023

Dry Powder Inhalers (DPIs) are, where clinically appropriate, the preferred devices to be used. In COPD combination inhalers should be used wherever possible.


Formoterol
Formulary

Oxis 6 Turbohaler® 6micrograms/inhalation
Oxis 12 Turbohaler® 12micrograms/inhalation
Easyhaler® 12 micrograms/metered inhalation
Atimos Modulite® 12 micrograms/metered inhalation

To be used as 1st line LABA when used in combination with ICS for asthma (combination inhalers preferred)


Green View adult BNF  View SPC online  View childrens BNF
Salmeterol Long acting
Formulary

Serevent® metered dose inhaler 25micrograms/inhalation
Serevent Accuhaler® 50micrograms/inhalation

COPD and Asthma


Amber 0 View adult BNF  View SPC online  View childrens BNF